FDA steps up scrutiny of stem cell therapies – Reuters
Reuters |
FDA steps up scrutiny of stem cell therapies
Reuters A small number of "unscrupulous actors" have seized on the promise of regenerative medicine and stem cell therapies to mislead patients based on unproven, and in some cases, dangerously dubious products, the FDA said on Monday. (bit.ly/2iB4Xls). |
